ClinConnect ClinConnect Logo
Search / Trial NCT06673979

Risk Factors for Chronic Postoperative Pain After Elective Nephrectomy

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Nov 2, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Chronic Pain Nephrectomy Surgery Pain Risk Factors Acute Pain Postoperative Pain

ClinConnect Summary

This clinical trial is studying the risk factors that can lead to chronic pain after a type of surgery called elective nephrectomy, which involves removing a kidney. The goal is to understand how much pain patients experience at different times after the surgery—specifically, one hour, three months, and one year later. To measure this pain, researchers will use a simple scale from 0 (no pain) to 10 (worst pain imaginable). By identifying patients who might be at higher risk for chronic pain, the study aims to find ways to help reduce this pain and improve overall recovery.

To participate in this trial, patients need to be between 18 and 90 years old and undergoing elective nephrectomy while receiving general anesthesia. The study will include a range of patients, regardless of gender, but will exclude anyone who cannot be contacted after the surgery or who passes away within a year. If you join the study, you can expect to share your pain experiences at the specified times, and this information will help researchers learn more about managing pain after surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria: -Patients aged 18-90 years,
  • ASA I-IV,
  • undergoing elective nephrectomy under general anesthesia will be included in the study.
  • Exclusion Criteria:
  • Patients who cannot be reached by phone and hose who die within the 1-year postoperative period will be excluded from the study.

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Patients applied

0 patients applied

Trial Officials

Aylin Nizamoglu, Doctor

Study Director

Istanbul Univerisity-Cerrahpasa Cerrahpasa Faculty of Medicine

Safak E Erbabacan, associate professor

Study Chair

Istanbul Univerisity-Cerrahpasa Cerrahpasa Faculty of Medicine

Fatis Altindas, Professor

Study Chair

Istanbul Univerisity-Cerrahpasa Cerrahpasa Faculty of Medicine

Ilayda Bilgili Altuntas, Physician

Principal Investigator

Istanbul Univerisity-Cerrahpasa Cerrahpasa Faculty of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported